▶ 調査レポート

医療用生物医学材料3.0のグローバル市場 2021年:企業別、地域別、種類・用途別

• 英文タイトル:Global Medical Biomedical Materials 3.0 Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026

GlobalInfoResearchが調査・発行した産業分析レポートです。医療用生物医学材料3.0のグローバル市場 2021年:企業別、地域別、種類・用途別 / Global Medical Biomedical Materials 3.0 Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026 / GIR-203B02569資料のイメージです。• レポートコード:GIR-203B02569
• 出版社/出版日:GlobalInfoResearch / 2021年12月
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、100ページ
• 納品方法:Eメール(納期:2~3日)
• 産業分類:化学&材料
• 販売価格(消費税別)
  Single User¥487,200 (USD3,480)▷ お問い合わせ
  Multi User¥730,800 (USD5,220)▷ お問い合わせ
  Corporate User¥974,400 (USD6,960)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
医療用生物医学材料3.0市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界の医療用生物医学材料3.0の市場規模は2020年のxxx米ドルから2021年にはxxx米ドルと推定され、2020年から2021年の間にxxx%の変化があります。世界の医療用生物医学材料3.0の市場規模は次の5年間でxxx%のCAGRで成長すると予想されます。

医療用生物医学材料3.0市場は種類と用途によって区分されます。2016年~2026年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・PLA、PGA、PLGA、PLCG、その他

用途別セグメントは次のように区分されます。
・縫合、骨折固定、口腔インプラント、ドラッグデリバリーミクロスフェア、その他

世界の医療用生物医学材料3.0市場の主要な市場プレーヤーは以下のとおりです。
・Merck、PCAS、Fujifilm、Evonik Health Care、Nomisma Healthcare、Corbion、DURECT、Mitsui Chemicals、Phosphorex Inc.、Lattice Medical、Jinan Daigang Biomaterial、Shenzhen Polymtek Biomaterial Co., Ltd.、Changchun Foliaplast Bio-tech Co., Ltd

地域別セグメントは次の地域・国をカバーします。
・北米(米国、カナダ、メキシコ)
・ヨーロッパ(ドイツ、フランス、イギリス、ロシア、イタリア)
・アジア太平洋(日本、中国、韓国、インド、東南アジア、オーストラリア)
・南アメリカ(ブラジル、アルゼンチン、コロンビア)
・中東およびアフリカ(サウジアラビア、UAE、エジプト、南アフリカ)

本調査レポートの内容は計14章あります。
・第1章では、医療用生物医学材料3.0製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な医療用生物医学材料3.0メーカーの企業概要、2019年~2021年までの医療用生物医学材料3.0の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な医療用生物医学材料3.0メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2016年~2026年までの地域別医療用生物医学材料3.0の販売量、売上、成長性を示しています。
・第5、6章では、2016年~2026年までの医療用生物医学材料3.0の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2016年~2021年までの世界の主要国での販売量、売上、市場シェア、並びに2021年~2026年までの主要地域での医療用生物医学材料3.0市場予測を収録しています。
・第12、13、14章では、医療用生物医学材料3.0の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
・メーカー情報(企業概要、製品概要、販売量、価格、売上):Merck、PCAS、Fujifilm、Evonik Health Care、Nomisma Healthcare、Corbion、DURECT、Mitsui Chemicals、Phosphorex Inc.、Lattice Medical、Jinan Daigang Biomaterial、Shenzhen Polymtek Biomaterial Co., Ltd.、Changchun Foliaplast Bio-tech Co., Ltd
・メーカー別市場シェア
・地域別市場分析2016年-2026年
・種類別分析2016年-2026年:PLA、PGA、PLGA、PLCG、その他
・用途別分析2016年-2026年:縫合、骨折固定、口腔インプラント、ドラッグデリバリーミクロスフェア、その他
・医療用生物医学材料3.0の北米市場規模2016年-2026年:アメリカ、カナダ、メキシコ
・医療用生物医学材料3.0のヨーロッパ市場規模2016年-2026年:ドイツ、イギリス、フランス、ロシア、イタリア
・医療用生物医学材料3.0のアジア市場規模2016年-2026年:中国、日本、韓国、インド、東南アジア、オーストラリア
・医療用生物医学材料3.0の南米市場規模2016年-2026年:ブラジル、アルゼンチン
・医療用生物医学材料3.0の中東・アフリカ市場規模2016年-2026年:サウジアラビア、トルコ、エジプト、南アフリカ
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Medical Biomedical Materials 3.0 market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Medical Biomedical Materials 3.0 size is estimated to be xx million in 2021 from USD xx million in 2020, with a change of XX% between 2020 and 2021. The global Medical Biomedical Materials 3.0 market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation
Medical Biomedical Materials 3.0 market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
PLA
PGA
PLGA
PLCG
Other

Market segment by Application can be divided into
Suture
Fracture Fixation
Oral Implant
Drug Delivery Microsphere
Others

The key market players for global Medical Biomedical Materials 3.0 market are listed below:
Merck
PCAS
Fujifilm
Evonik Health Care
Nomisma Healthcare
Corbion
DURECT
Mitsui Chemicals
Phosphorex Inc.
Lattice Medical
Jinan Daigang Biomaterial
Shenzhen Polymtek Biomaterial Co., Ltd.
Changchun Foliaplast Bio-tech Co., Ltd

Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe Medical Biomedical Materials 3.0 product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Medical Biomedical Materials 3.0, with price, sales, revenue and global market share of Medical Biomedical Materials 3.0 in 2018 and 2019.
Chapter 3, the Medical Biomedical Materials 3.0 competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Medical Biomedical Materials 3.0 breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Medical Biomedical Materials 3.0 market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe Medical Biomedical Materials 3.0 sales channel, distributors, customers, research findings and conclusion, appendix and data source.

レポート目次

1 Market Overview
1.1 Medical Biomedical Materials 3.0 Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Medical Biomedical Materials 3.0 Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 PLA
1.2.3 PGA
1.2.4 PLGA
1.2.5 PLCG
1.2.6 Other
1.3 Market Analysis by Application
1.3.1 Overview: Global Medical Biomedical Materials 3.0 Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Suture
1.3.3 Fracture Fixation
1.3.4 Oral Implant
1.3.5 Drug Delivery Microsphere
1.3.6 Others
1.4 Global Medical Biomedical Materials 3.0 Market Size & Forecast
1.4.1 Global Medical Biomedical Materials 3.0 Sales in Value (2016-2026))
1.4.2 Global Medical Biomedical Materials 3.0 Sales in Volume (2016-2026)
1.4.3 Global Medical Biomedical Materials 3.0 Price by Type (2016-2026) & (US$/Ton)
1.5 Global Medical Biomedical Materials 3.0 Production Capacity Analysis
1.5.1 Global Medical Biomedical Materials 3.0 Total Production Capacity (2016-2026)
1.5.2 Global Medical Biomedical Materials 3.0 Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Medical Biomedical Materials 3.0 Market Drivers
1.6.2 Medical Biomedical Materials 3.0 Market Restraints
1.6.3 Medical Biomedical Materials 3.0 Trends Analysis
2 Manufacturers Profiles
2.1 Merck
2.1.1 Merck Details
2.1.2 Merck Major Business
2.1.3 Merck Medical Biomedical Materials 3.0 Product and Services
2.1.4 Merck Medical Biomedical Materials 3.0 Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.2 PCAS
2.2.1 PCAS Details
2.2.2 PCAS Major Business
2.2.3 PCAS Medical Biomedical Materials 3.0 Product and Services
2.2.4 PCAS Medical Biomedical Materials 3.0 Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.3 Fujifilm
2.3.1 Fujifilm Details
2.3.2 Fujifilm Major Business
2.3.3 Fujifilm Medical Biomedical Materials 3.0 Product and Services
2.3.4 Fujifilm Medical Biomedical Materials 3.0 Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.4 Evonik Health Care
2.4.1 Evonik Health Care Details
2.4.2 Evonik Health Care Major Business
2.4.3 Evonik Health Care Medical Biomedical Materials 3.0 Product and Services
2.4.4 Evonik Health Care Medical Biomedical Materials 3.0 Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.5 Nomisma Healthcare
2.5.1 Nomisma Healthcare Details
2.5.2 Nomisma Healthcare Major Business
2.5.3 Nomisma Healthcare Medical Biomedical Materials 3.0 Product and Services
2.5.4 Nomisma Healthcare Medical Biomedical Materials 3.0 Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.6 Corbion
2.6.1 Corbion Details
2.6.2 Corbion Major Business
2.6.3 Corbion Medical Biomedical Materials 3.0 Product and Services
2.6.4 Corbion Medical Biomedical Materials 3.0 Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.7 DURECT
2.7.1 DURECT Details
2.7.2 DURECT Major Business
2.7.3 DURECT Medical Biomedical Materials 3.0 Product and Services
2.7.4 DURECT Medical Biomedical Materials 3.0 Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.8 Mitsui Chemicals
2.8.1 Mitsui Chemicals Details
2.8.2 Mitsui Chemicals Major Business
2.8.3 Mitsui Chemicals Medical Biomedical Materials 3.0 Product and Services
2.8.4 Mitsui Chemicals Medical Biomedical Materials 3.0 Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.9 Phosphorex Inc.
2.9.1 Phosphorex Inc. Details
2.9.2 Phosphorex Inc. Major Business
2.9.3 Phosphorex Inc. Medical Biomedical Materials 3.0 Product and Services
2.9.4 Phosphorex Inc. Medical Biomedical Materials 3.0 Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.10 Lattice Medical
2.10.1 Lattice Medical Details
2.10.2 Lattice Medical Major Business
2.10.3 Lattice Medical Medical Biomedical Materials 3.0 Product and Services
2.10.4 Lattice Medical Medical Biomedical Materials 3.0 Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.11 Jinan Daigang Biomaterial
2.11.1 Jinan Daigang Biomaterial Details
2.11.2 Jinan Daigang Biomaterial Major Business
2.11.3 Jinan Daigang Biomaterial Medical Biomedical Materials 3.0 Product and Services
2.11.4 Jinan Daigang Biomaterial Medical Biomedical Materials 3.0 Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.12 Shenzhen Polymtek Biomaterial Co., Ltd.
2.12.1 Shenzhen Polymtek Biomaterial Co., Ltd. Details
2.12.2 Shenzhen Polymtek Biomaterial Co., Ltd. Major Business
2.12.3 Shenzhen Polymtek Biomaterial Co., Ltd. Medical Biomedical Materials 3.0 Product and Services
2.12.4 Shenzhen Polymtek Biomaterial Co., Ltd. Medical Biomedical Materials 3.0 Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.13 Changchun Foliaplast Bio-tech Co., Ltd
2.13.1 Changchun Foliaplast Bio-tech Co., Ltd Details
2.13.2 Changchun Foliaplast Bio-tech Co., Ltd Major Business
2.13.3 Changchun Foliaplast Bio-tech Co., Ltd Medical Biomedical Materials 3.0 Product and Services
2.13.4 Changchun Foliaplast Bio-tech Co., Ltd Medical Biomedical Materials 3.0 Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 Medical Biomedical Materials 3.0 Sales by Manufacturer
3.1 Global Medical Biomedical Materials 3.0 Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Medical Biomedical Materials 3.0 Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Medical Biomedical Materials 3.0
3.4 Market Concentration Rate
3.4.1 Top 3 Medical Biomedical Materials 3.0 Manufacturer Market Share
3.4.2 Top 6 Medical Biomedical Materials 3.0 Manufacturer Market Share
3.5 Global Medical Biomedical Materials 3.0 Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Medical Biomedical Materials 3.0 Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Medical Biomedical Materials 3.0 Market Size by Region
4.1.1 Global Medical Biomedical Materials 3.0 Sales in Volume by Region (2016-2026)
4.1.2 Global Medical Biomedical Materials 3.0 Revenue by Region (2016-2026)
4.2 North America Medical Biomedical Materials 3.0 Revenue (2016-2026)
4.3 Europe Medical Biomedical Materials 3.0 Revenue (2016-2026)
4.4 Asia-Pacific Medical Biomedical Materials 3.0 Revenue (2016-2026)
4.5 South America Medical Biomedical Materials 3.0 Revenue (2016-2026)
4.6 Middle East and Africa Medical Biomedical Materials 3.0 Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Medical Biomedical Materials 3.0 Sales in Volume by Type (2016-2026)
5.2 Global Medical Biomedical Materials 3.0 Revenue by Type (2016-2026)
5.3 Global Medical Biomedical Materials 3.0 Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Medical Biomedical Materials 3.0 Sales in Volume by Application (2016-2026)
6.2 Global Medical Biomedical Materials 3.0 Revenue by Application (2016-2026)
6.3 Global Medical Biomedical Materials 3.0 Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Medical Biomedical Materials 3.0 Sales by Type (2016-2026)
7.2 North America Medical Biomedical Materials 3.0 Sales by Application (2016-2026)
7.3 North America Medical Biomedical Materials 3.0 Market Size by Country
7.3.1 North America Medical Biomedical Materials 3.0 Sales in Volume by Country (2016-2026)
7.3.2 North America Medical Biomedical Materials 3.0 Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Medical Biomedical Materials 3.0 Sales by Type (2016-2026)
8.2 Europe Medical Biomedical Materials 3.0 Sales by Application (2016-2026)
8.3 Europe Medical Biomedical Materials 3.0 Market Size by Country
8.3.1 Europe Medical Biomedical Materials 3.0 Sales in Volume by Country (2016-2026)
8.3.2 Europe Medical Biomedical Materials 3.0 Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Medical Biomedical Materials 3.0 Sales by Type (2016-2026)
9.2 Asia-Pacific Medical Biomedical Materials 3.0 Sales by Application (2016-2026)
9.3 Asia-Pacific Medical Biomedical Materials 3.0 Market Size by Region
9.3.1 Asia-Pacific Medical Biomedical Materials 3.0 Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Medical Biomedical Materials 3.0 Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Medical Biomedical Materials 3.0 Sales by Type (2016-2026)
10.2 South America Medical Biomedical Materials 3.0 Sales by Application (2016-2026)
10.3 South America Medical Biomedical Materials 3.0 Market Size by Country
10.3.1 South America Medical Biomedical Materials 3.0 Sales in Volume by Country (2016-2026)
10.3.2 South America Medical Biomedical Materials 3.0 Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Medical Biomedical Materials 3.0 Sales by Type (2016-2026)
11.2 Middle East & Africa Medical Biomedical Materials 3.0 Sales by Application (2016-2026)
11.3 Middle East & Africa Medical Biomedical Materials 3.0 Market Size by Country
11.3.1 Middle East & Africa Medical Biomedical Materials 3.0 Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Medical Biomedical Materials 3.0 Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Medical Biomedical Materials 3.0 Typical Distributors
12.3 Medical Biomedical Materials 3.0 Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer

List of Tables
Table 1. Global Medical Biomedical Materials 3.0 Revenue by Type, (USD Million), 2021-2026
Table 2. Global Medical Biomedical Materials 3.0 Revenue by Application, (USD Million), 2021-2026
Table 3. Merck Basic Information, Manufacturing Base and Competitors
Table 4. Merck Major Business
Table 5. Merck Medical Biomedical Materials 3.0 Product and Services
Table 6. Merck Medical Biomedical Materials 3.0 Sales (Ton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. PCAS Basic Information, Manufacturing Base and Competitors
Table 8. PCAS Major Business
Table 9. PCAS Medical Biomedical Materials 3.0 Product and Services
Table 10. PCAS Medical Biomedical Materials 3.0 Sales (Ton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Fujifilm Basic Information, Manufacturing Base and Competitors
Table 12. Fujifilm Major Business
Table 13. Fujifilm Medical Biomedical Materials 3.0 Product and Services
Table 14. Fujifilm Medical Biomedical Materials 3.0 Sales (Ton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Evonik Health Care Basic Information, Manufacturing Base and Competitors
Table 16. Evonik Health Care Major Business
Table 17. Evonik Health Care Medical Biomedical Materials 3.0 Product and Services
Table 18. Evonik Health Care Medical Biomedical Materials 3.0 Sales (Ton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Nomisma Healthcare Basic Information, Manufacturing Base and Competitors
Table 20. Nomisma Healthcare Major Business
Table 21. Nomisma Healthcare Medical Biomedical Materials 3.0 Product and Services
Table 22. Nomisma Healthcare Medical Biomedical Materials 3.0 Sales (Ton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Corbion Basic Information, Manufacturing Base and Competitors
Table 24. Corbion Major Business
Table 25. Corbion Medical Biomedical Materials 3.0 Product and Services
Table 26. Corbion Medical Biomedical Materials 3.0 Sales (Ton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. DURECT Basic Information, Manufacturing Base and Competitors
Table 28. DURECT Major Business
Table 29. DURECT Medical Biomedical Materials 3.0 Product and Services
Table 30. DURECT Medical Biomedical Materials 3.0 Sales (Ton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Mitsui Chemicals Basic Information, Manufacturing Base and Competitors
Table 32. Mitsui Chemicals Major Business
Table 33. Mitsui Chemicals Medical Biomedical Materials 3.0 Product and Services
Table 34. Mitsui Chemicals Medical Biomedical Materials 3.0 Sales (Ton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Phosphorex Inc. Basic Information, Manufacturing Base and Competitors
Table 36. Phosphorex Inc. Major Business
Table 37. Phosphorex Inc. Medical Biomedical Materials 3.0 Product and Services
Table 38. Phosphorex Inc. Medical Biomedical Materials 3.0 Sales (Ton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Lattice Medical Basic Information, Manufacturing Base and Competitors
Table 40. Lattice Medical Major Business
Table 41. Lattice Medical Medical Biomedical Materials 3.0 Product and Services
Table 42. Lattice Medical Medical Biomedical Materials 3.0 Sales (Ton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. Jinan Daigang Biomaterial Basic Information, Manufacturing Base and Competitors
Table 44. Jinan Daigang Biomaterial Major Business
Table 45. Jinan Daigang Biomaterial Medical Biomedical Materials 3.0 Product and Services
Table 46. Jinan Daigang Biomaterial Medical Biomedical Materials 3.0 Sales (Ton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 47. Shenzhen Polymtek Biomaterial Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 48. Shenzhen Polymtek Biomaterial Co., Ltd. Major Business
Table 49. Shenzhen Polymtek Biomaterial Co., Ltd. Medical Biomedical Materials 3.0 Product and Services
Table 50. Shenzhen Polymtek Biomaterial Co., Ltd. Medical Biomedical Materials 3.0 Sales (Ton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 51. Changchun Foliaplast Bio-tech Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 52. Changchun Foliaplast Bio-tech Co., Ltd Major Business
Table 53. Changchun Foliaplast Bio-tech Co., Ltd Medical Biomedical Materials 3.0 Product and Services
Table 54. Changchun Foliaplast Bio-tech Co., Ltd Medical Biomedical Materials 3.0 Sales (Ton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 55. Global Medical Biomedical Materials 3.0 Sales by Manufacturer (2019-2021e) & (Ton)
Table 56. Global Medical Biomedical Materials 3.0 Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 57. Market Position of Manufacturers in Medical Biomedical Materials 3.0, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 58. Global Medical Biomedical Materials 3.0 Production Capacity by Company, (Ton): 2020 VS 2021
Table 59. Head Office and Medical Biomedical Materials 3.0 Production Site of Key Manufacturer
Table 60. Medical Biomedical Materials 3.0 New Entrant and Capacity Expansion Plans
Table 61. Medical Biomedical Materials 3.0 Mergers & Acquisitions in the Past Five Years
Table 62. Global Medical Biomedical Materials 3.0 Sales by Region (2016-2021e) & (Ton)
Table 63. Global Medical Biomedical Materials 3.0 Sales by Region (2021-2026) & (Ton)
Table 64. Global Medical Biomedical Materials 3.0 Revenue by Region (2016-2021e) & (USD Million)
Table 65. Global Medical Biomedical Materials 3.0 Revenue by Region (2021-2026) & (USD Million)
Table 66. Global Medical Biomedical Materials 3.0 Sales by Type (2016-2021e) & (Ton)
Table 67. Global Medical Biomedical Materials 3.0 Sales by Type (2021-2026) & (Ton)
Table 68. Global Medical Biomedical Materials 3.0 Revenue by Type (2016-2021e) & (USD Million)
Table 69. Global Medical Biomedical Materials 3.0 Revenue by Type (2021-2026) & (USD Million)
Table 70. Global Medical Biomedical Materials 3.0 Price by Type (2016-2021e) & (US$/Ton)
Table 71. Global Medical Biomedical Materials 3.0 Price by Type (2021-2026) & (US$/Ton)
Table 72. Global Medical Biomedical Materials 3.0 Sales by Application (2016-2021e) & (Ton)
Table 73. Global Medical Biomedical Materials 3.0 Sales by Application (2021-2026) & (Ton)
Table 74. Global Medical Biomedical Materials 3.0 Revenue by Application (2016-2021e) & (USD Million)
Table 75. Global Medical Biomedical Materials 3.0 Revenue by Application (2021-2026) & (USD Million)
Table 76. Global Medical Biomedical Materials 3.0 Price by Application (2016-2021e) & (US$/Ton)
Table 77. Global Medical Biomedical Materials 3.0 Price by Application (2021-2026) & (US$/Ton)
Table 78. North America Medical Biomedical Materials 3.0 Sales by Country (2016-2021e) & (Ton)
Table 79. North America Medical Biomedical Materials 3.0 Sales by Country (2021-2026) & (Ton)
Table 80. North America Medical Biomedical Materials 3.0 Revenue by Country (2016-2021e) & (USD Million)
Table 81. North America Medical Biomedical Materials 3.0 Revenue by Country (2021-2026) & (USD Million)
Table 82. North America Medical Biomedical Materials 3.0 Sales by Type (2016-2021e) & (Ton)
Table 83. North America Medical Biomedical Materials 3.0 Sales by Type (2021-2026) & (Ton)
Table 84. North America Medical Biomedical Materials 3.0 Sales by Application (2016-2021e) & (Ton)
Table 85. North America Medical Biomedical Materials 3.0 Sales by Application (2021-2026) & (Ton)
Table 86. Europe Medical Biomedical Materials 3.0 Sales by Country (2016-2021e) & (Ton)
Table 87. Europe Medical Biomedical Materials 3.0 Sales by Country (2021-2026) & (Ton)
Table 88. Europe Medical Biomedical Materials 3.0 Revenue by Country (2016-2021e) & (USD Million)
Table 89. Europe Medical Biomedical Materials 3.0 Revenue by Country (2021-2026) & (USD Million)
Table 90. Europe Medical Biomedical Materials 3.0 Sales by Type (2016-2021e) & (Ton)
Table 91. Europe Medical Biomedical Materials 3.0 Sales by Type (2021-2026) & (Ton)
Table 92. Europe Medical Biomedical Materials 3.0 Sales by Application (2016-2021e) & (Ton)
Table 93. Europe Medical Biomedical Materials 3.0 Sales by Application (2021-2026) & (Ton)
Table 94. Asia-Pacific Medical Biomedical Materials 3.0 Sales by Region (2016-2021e) & (Ton)
Table 95. Asia-Pacific Medical Biomedical Materials 3.0 Sales by Region (2021-2026) & (Ton)
Table 96. Asia-Pacific Medical Biomedical Materials 3.0 Revenue by Region (2016-2021e) & (USD Million)
Table 97. Asia-Pacific Medical Biomedical Materials 3.0 Revenue by Region (2021-2026) & (USD Million)
Table 98. Asia-Pacific Medical Biomedical Materials 3.0 Sales by Type (2016-2021e) & (Ton)
Table 99. Asia-Pacific Medical Biomedical Materials 3.0 Sales by Type (2021-2026) & (Ton)
Table 100. Asia-Pacific Medical Biomedical Materials 3.0 Sales by Application (2016-2021e) & (Ton)
Table 101. Asia-Pacific Medical Biomedical Materials 3.0 Sales by Application (2021-2026) & (Ton)
Table 102. South America Medical Biomedical Materials 3.0 Sales by Country (2016-2021e) & (Ton)
Table 103. South America Medical Biomedical Materials 3.0 Sales by Country (2021-2026) & (Ton)
Table 104. South America Medical Biomedical Materials 3.0 Revenue by Country (2016-2021e) & (USD Million)
Table 105. South America Medical Biomedical Materials 3.0 Revenue by Country (2021-2026) & (USD Million)
Table 106. South America Medical Biomedical Materials 3.0 Sales by Type (2016-2021e) & (Ton)
Table 107. South America Medical Biomedical Materials 3.0 Sales by Type (2021-2026) & (Ton)
Table 108. South America Medical Biomedical Materials 3.0 Sales by Application (2016-2021e) & (Ton)
Table 109. South America Medical Biomedical Materials 3.0 Sales by Application (2021-2026) & (Ton)
Table 110. Middle East & Africa Medical Biomedical Materials 3.0 Sales by Country (2016-2021e) & (Ton)
Table 111. Middle East & Africa Medical Biomedical Materials 3.0 Sales by Country (2021-2026) & (Ton)
Table 112. Middle East & Africa Medical Biomedical Materials 3.0 Revenue by Country (2016-2021e) & (USD Million)
Table 113. Middle East & Africa Medical Biomedical Materials 3.0 Revenue by Country (2021-2026) & (USD Million)
Table 114. Middle East & Africa Medical Biomedical Materials 3.0 Sales by Type (2016-2021e) & (Ton)
Table 115. Middle East & Africa Medical Biomedical Materials 3.0 Sales by Type (2021-2026) & (Ton)
Table 116. Middle East & Africa Medical Biomedical Materials 3.0 Sales by Application (2016-2021e) & (Ton)
Table 117. Middle East & Africa Medical Biomedical Materials 3.0 Sales by Application (2021-2026) & (Ton)
Table 118. Direct Channel Pros & Cons
Table 119. Indirect Channel Pros & Cons
Table 120. Medical Biomedical Materials 3.0 Typical Distributors
Table 121. Medical Biomedical Materials 3.0 Typical Customers
List of Figures
Figure 1. Medical Biomedical Materials 3.0 Picture
Figure 2. Global Medical Biomedical Materials 3.0 Sales Market Share by Type in 2020
Figure 3. PLA
Figure 4. PGA
Figure 5. PLGA
Figure 6. PLCG
Figure 7. Other
Figure 8. Global Medical Biomedical Materials 3.0 Sales Market Share by Application in 2020
Figure 9. Suture
Figure 10. Fracture Fixation
Figure 11. Oral Implant
Figure 12. Drug Delivery Microsphere
Figure 13. Others
Figure 14. Global Medical Biomedical Materials 3.0 Market Size, (USD Million) & (Ton): 2020 VS 2021 VS 2026
Figure 15. Global Medical Biomedical Materials 3.0 Market Size and Forecast (2016-2026) & (USD Million)
Figure 16. Global Medical Biomedical Materials 3.0 Sales (2016-2026) & (Ton)
Figure 17. Global Medical Biomedical Materials 3.0 Price by Type (2016-2026) & (US$/Ton)
Figure 18. Global Medical Biomedical Materials 3.0 Production Capacity (2016-2026) & (Ton)
Figure 19. Global Medical Biomedical Materials 3.0 Production Capacity by Geographic Region: 2020 VS 2021
Figure 20. Medical Biomedical Materials 3.0 Market Drivers
Figure 21. Medical Biomedical Materials 3.0 Market Restraints
Figure 22. Medical Biomedical Materials 3.0 Market Trends
Figure 23. Global Medical Biomedical Materials 3.0 Sales Market Share by Manufacturer in 2020
Figure 24. Global Medical Biomedical Materials 3.0 Revenue Market Share by Manufacturer in 2020
Figure 25. Medical Biomedical Materials 3.0 Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 26. Top 3 Medical Biomedical Materials 3.0 Manufacturer (Revenue) Market Share in 2020
Figure 27. Top 6 Medical Biomedical Materials 3.0 Manufacturer (Revenue) Market Share in 2020
Figure 28. Global Medical Biomedical Materials 3.0 Sales Market Share by Region (2016-2026)
Figure 29. Global Medical Biomedical Materials 3.0 Revenue Market Share by Region (2016-2026)
Figure 30. North America Medical Biomedical Materials 3.0 Revenue (2016-2026) & (USD Million)
Figure 31. Europe Medical Biomedical Materials 3.0 Revenue (2016-2026) & (USD Million)
Figure 32. Asia-Pacific Medical Biomedical Materials 3.0 Revenue (2016-2026) & (USD Million)
Figure 33. South America Medical Biomedical Materials 3.0 Revenue (2016-2026) & (USD Million)
Figure 34. Middle East & Africa Medical Biomedical Materials 3.0 Revenue (2016-2026) & (USD Million)
Figure 35. Global Medical Biomedical Materials 3.0 Sales Market Share by Type (2016-2026)
Figure 36. Global Medical Biomedical Materials 3.0 Revenue Market Share by Type (2016-2026)
Figure 37. Global Medical Biomedical Materials 3.0 Price by Type (2016-2026) & (US$/Ton)
Figure 38. Global Medical Biomedical Materials 3.0 Sales Market Share by Application (2016-2026)
Figure 39. Global Medical Biomedical Materials 3.0 Revenue Market Share by Application (2016-2026)
Figure 40. Global Medical Biomedical Materials 3.0 Price by Application (2016-2026) & (US$/Ton)
Figure 41. North America Medical Biomedical Materials 3.0 Sales Market Share by Type (2016-2026)
Figure 42. North America Medical Biomedical Materials 3.0 Sales Market Share by Application (2016-2026)
Figure 43. North America Medical Biomedical Materials 3.0 Sales Market Share by Country (2016-2026)
Figure 44. North America Medical Biomedical Materials 3.0 Revenue Market Share by Country (2016-2026)
Figure 45. United States Medical Biomedical Materials 3.0 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 46. Canada Medical Biomedical Materials 3.0 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. Mexico Medical Biomedical Materials 3.0 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. Europe Medical Biomedical Materials 3.0 Sales Market Share by Type (2016-2026)
Figure 49. Europe Medical Biomedical Materials 3.0 Sales Market Share by Application (2016-2026)
Figure 50. Europe Medical Biomedical Materials 3.0 Sales Market Share by Country (2016-2026)
Figure 51. Europe Medical Biomedical Materials 3.0 Revenue Market Share by Country (2016-2026)
Figure 52. Germany Medical Biomedical Materials 3.0 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. France Medical Biomedical Materials 3.0 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. United Kingdom Medical Biomedical Materials 3.0 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Russia Medical Biomedical Materials 3.0 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Italy Medical Biomedical Materials 3.0 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Asia-Pacific Medical Biomedical Materials 3.0 Sales Market Share by Region (2016-2026)
Figure 58. Asia-Pacific Medical Biomedical Materials 3.0 Sales Market Share by Application (2016-2026)
Figure 59. Asia-Pacific Medical Biomedical Materials 3.0 Sales Market Share by Region (2016-2026)
Figure 60. Asia-Pacific Medical Biomedical Materials 3.0 Revenue Market Share by Region (2016-2026)
Figure 61. China Medical Biomedical Materials 3.0 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Japan Medical Biomedical Materials 3.0 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Korea Medical Biomedical Materials 3.0 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. India Medical Biomedical Materials 3.0 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. Southeast Asia Medical Biomedical Materials 3.0 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. Australia Medical Biomedical Materials 3.0 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. South America Medical Biomedical Materials 3.0 Sales Market Share by Type (2016-2026)
Figure 68. South America Medical Biomedical Materials 3.0 Sales Market Share by Application (2016-2026)
Figure 69. South America Medical Biomedical Materials 3.0 Sales Market Share by Country (2016-2026)
Figure 70. South America Medical Biomedical Materials 3.0 Revenue Market Share by Country (2016-2026)
Figure 71. Brazil Medical Biomedical Materials 3.0 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. Argentina Medical Biomedical Materials 3.0 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Middle East & Africa Medical Biomedical Materials 3.0 Sales Market Share by Type (2016-2026)
Figure 74. Middle East & Africa Medical Biomedical Materials 3.0 Sales Market Share by Application (2016-2026)
Figure 75. Middle East & Africa Medical Biomedical Materials 3.0 Sales Market Share by Country (2016-2026)
Figure 76. Middle East & Africa Medical Biomedical Materials 3.0 Revenue Market Share by Country (2016-2026)
Figure 77. Turkey Medical Biomedical Materials 3.0 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 78. Egypt Medical Biomedical Materials 3.0 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 79. Saudi Arabia Medical Biomedical Materials 3.0 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 80. South Africa Medical Biomedical Materials 3.0 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 81. Sales Channel: Direct Channel vs Indirect Channel
Figure 82. Methodology
Figure 83. Research Process and Data Source